The Journal and Constitution urged the FDA in an editorial to proceed with a proposal to require stronger warning labels on aspirin and similar over-the-counter painkillers. The editorial said a federal agency can do only so much, so it should be left to consumers to gauge their own use of the drugs.

Related Summaries